Answers are grounded in this paper and cite their sources.
OBJECTIVE: An abnormal diffusing capacity for carbon monoxide (DLco) is the most prevalent lung function abnormality seen in people with HIV, but the drivers of this phenotype are poorly understood. We aimed to understand the molecular mechanisms underlying abnormal DLco in the context of chronic HIV infection, both in the local lung environment and in circulating peripheral blood mononuclear cells (PBMCs). DESIGN: A cross-sectional, observational, and transcriptomic pilot study. METHODS: We collected and isolated PBMCs from eight PWH and bronchoalveolar lavage (BAL) cells from 29 PWH enrolled in the I AM OLD-DA study in San Francisco, CA. We conducted single-cell RNA sequencing (scRNA-seq) for PBMCs and bulk RNA-seq for BAL samples and performed downstream differential gene expression (DGE) and gene set enrichment analysis (GSEA). We used ATS/ERS-compliant pulmonary function tests (PFTs) to classify the participants' DLco as normal [DLco ≥ lower limit of normal (LLN)] or abnormal (DLco < LLN). RESULTS: In PBMCs, we observed upregulation of interferon pathways in CD4+ and CD8+ T cells and downregulation of TNF-α signaling across CD4+ T cells, CD8+ T cells, and monocytes in PWH with an abnormal DLco. Analysis of BAL revealed upregulation of PI3K-mTOR signaling, oxidative phosphorylation, and MYC target V1 pathways, which were not observed in major cell types from PBMCs. CONCLUSION: Abnormal DLco in PWH was associated with a shared interferon-driven transcriptional signature and broad downregulation of TNF-α signaling across multiple immune cell subsets, along with distinct metabolic pathway enrichment in BAL, suggesting separate systemic and pulmonary immune mechanisms.
No takes yet. Share an insight, caveat, or question.
Chung et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: